Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

Targeting men in the top 10% of genetic risk helped detect high-grade prostate cancer that conventional screening would miss, paving the way for more personalized and effective early detection ...

A large screening trial showed that using prostate-specific antigen density (PSAD) before MRI prevented overdiagnosis and lowered resource use while preserving the detection of clinically significant ...

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment ...

A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...

A major review of nearly 800,000 men has found prostate cancer screening using a specific test is likely to reduce deaths ...

The newly developed urine test helps identify which prostate cancer patients need a biopsy and which can safely skip the ...

To check for possible prostate cancer, physicians most often use prostate-specific antigen (PSA) tests and digital rectal exams (DREs). For a firm diagnosis, they use core needle biopsies. This page ...

New research indicates prostate cancer screening via PSA blood tests can significantly reduce deaths from the disease. While ...

A comprehensive study reveals prostate cancer screening saves lives, reducing deaths by two per 1,000 men screened, but many ...